**Glucotrack Receives Notice from Nasdaq Regarding Bid Price Rule Compliance**Washington, D.C., December 31, 2024 – Glucotrack, Inc. (NASDAQ: GCTK) recently received notification from the Nasdaq Stock Market LLC (“Nasdaq”) concerning its bid price fo

* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GlucoTrack’s 8K filing here. About GlucoTrack (Get Free Report) GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the […]

Leave a Reply

Your email address will not be published.

Previous post Patriots cut veteran pass rusher before season finale
Next post Canada Carbon (CVE:CCB) Shares Up 100% – Should You Buy?